| Comparing an imaging-guided pathway with the standard pathway for staging muscle-invasive bladder cancer: preliminary data from the BladderPath study RT Bryan, W Liu, SJ Pirrie, R Amir, J Gallagher, AI Hughes, KP Jefferson, ... European urology 80 (1), 12-15, 2021 | 42 | 2021 |
| Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath study. ND James, S Pirrie, W Liu, R Amir, J Gallagher, A Hughes, K Jefferson, ... Journal of Clinical Oncology 38 (6_suppl), 446-446, 2020 | 6 | 2020 |
| Urine DNA for monitoring chemoradiotherapy response in muscle‐invasive bladder cancer: a pilot study NS Gordon, LA Baxter, A Goel, R Arnold, B Kaur, W Liu, SJ Pirrie, ... BJU international 129 (1), 32-34, 2022 | 3 | 2022 |
| Group-sequential response-adaptive designs for censored survival outcomes W Liu, DS Coad Journal of Statistical Planning and Inference 205, 293-305, 2020 | 1 | 2020 |
| A phase I/II feasibility study of cetuximab with 5FU and mitomycin C or cisplatin with concurrent radiotherapy in muscle invasive bladder cancer. ND James, S Pirrie, W Liu, D Ford, A Zarkar, E Southgate, A Desai, ... Journal of Clinical Oncology 38 (6_suppl), 491-491, 2020 | 1 | 2020 |
| Replacing TURBT with mpMRI for staging MIBC: Pilot data from the BladderPath trial RT Bryan, SJ Pirrie, W Liu, R Amir, J Gallagher, AI Hughes, KP Jefferson, ... European Urology Open Science 19, e824-e825, 2020 | | 2020 |
| Group-Sequential Response-Adaptive Designs for Comparing Several Treatments W Liu Queen Mary University of London, 2017 | | 2017 |
